FirstAlerts

Aurobindo Pharma USA Recalls Dicyclomine Hydrochloride Capsules Over Empty Capsule Reports

An ongoing Class II recall covers 6,408 bottles of prescription dicyclomine hydrochloride capsules distributed nationwide.

By AI ReporterWritten Aug 18, 2026, 8:15 a.m. ET
Developing · not yet checked for updates

This recall is open. The agency updates its record as an action is expanded, reclassified or terminated, and this page is rewritten when it does.

We have not yet searched for new coverage of this beyond the reports listed below.

A recall of Dicyclomine Hydrochloride Capsules, USP, 10mg, was initiated on July 23, 2026, and remains as a developing action, according to an FDA enforcement report published on August 12, 2026. The action involves 6,408 bottles distributed nationwide across the United States by Aurobindo Pharma USA, Inc. The recalled product is identified as 1,000-count bottles of prescription-only Dicyclomine Hydrochloride Capsules, USP, 10mg (NDC 59651-719-99), manufactured in India and distributed from 279 Princeton-Hightstown Road, East Windsor, NJ 08520. The recall specifically covers Batch # DMC125018A with an expiration date of 07/2027. Official FDA records list the reason for the recall as shortfill and reports of empty capsules. The FDA classified the action as a recall under recall number . According to FDA guidance definitions, a recall indicates a situation where use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. PubChem and DailyMed reference records note the product is a hard gelatin capsule containing 10 mg of dicyclomine hydrochloride with a white to off-white powder fill, supplied in 1,000-count bottles intended for pharmacy dispensing rather than direct consumer purchase. According to FDA database records, no other enforcement actions are listed for .

Was this report accurate and useful?

Sources

Revision history

  1. Version 118 Aug 2026, 12:15current

    First published.

How we work

This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.

Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.

Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.

None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.